Lyra Therapeutics (NASDAQ:LYRA – Get Rating) and Intelligent Bio Solutions (NASDAQ:INBS – Get Rating) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their profitability, valuation, dividends, earnings, analyst recommendations, institutional ownership and risk. Profitability This table compares Lyra Therapeutics and Intelligent […]
Friday's impressive 13% surge in the shares of Lyra Therapeutics (NASDAQ:LYRA) carried over into the new week as investors pushed the LYRA stock price up a further 8.6% on Monday.
Lyra Therapeutics, Inc. (NASDAQ:LYRA – Get Rating) major shareholder Nbvm Gp, Llc purchased 1,805,416 shares of the firm’s stock in a transaction dated Wednesday, May 31st. The shares were bought at an average price of $2.43 per share, with a total value of $4,387,160.88. Following the purchase, the insider now owns 2,521,745 shares in the […]
WATERTOWN, Mass., May 26, 2023 Lyra Therapeutics, Inc. , a clinical-stage biotechnology company developing innovative therapies for the localized treatment of chronic rhinosinusitis, today. | May 26, 2023